Font Size: a A A
Keyword [muscle-invasive bladder cancer]
Result: 181 - 200 | Page: 10 of 10
181. Differential Analysis Of Single-cell Transcriptome Sequencing For Microenvironment Between Muscle-invasive Bladder Cancer And Adjacent Tissue
182. Meta Analysis Of Clinical Efficacy Of Neoadjuvant Chemotherapy For Muscle-invasive Bladder Cancer
183. Analysis Of The Risk Of Recurrence Of CK20 And Ki67 In Non-Muscle Invasive Bladder Cancer
184. Experimental Study On Urine Endogenous Cannabinoid As A Diagnostic Biomarker For Non-Muscle-Invasive Bladder Cancer
185. Clinical Efficacy Of CTURBT Combined With Systemic Chemotherapy For Muscle-invasive Bladder Cancer （T2N0M0）
186. A Meta-analysis Of The Safety And Efficacy Of Endoscopic Submucosal Dissection In The Treatment Of Non-muscle-invasive Bladder Tumors
187. Clinical Study Of Arterial Infusion Chemotherapy Combined With Drug-eluting Bead Transarterial Chemoembolization For Treatment Of Muscle-invasive Bladder Cancer
188. Correlation Of Preoperative Plasma Fibrinogen And Systemic Immune-inflammation Index With Prognosis Of Non-muscle Invasive Bladder Cancer
189. Efficacy Analysis Of Thulium Laser En-bloc Resection Of Bladder Tumor Versus Plasm Akinetic Transurethral Resection Of Bladder Tumor For Non-muscle Invasive Bladder Cancer
190. Preoperative Sarcopenia And Systemic Immune-inflammation Index Can Predict Response To Intravesical Bacillus Calmette-Guerininstillation In Patients With Non-muscle Invasive Bladder Cancer
191. Research On The Correlation Between Preoperative Urine PH And The Recurrence Of Non-Muscle-Invasive Bladder Cancer Patients,and The Development And Validation Of A Recurrence Risk Model
192. Association Between Metabolic Syndrome And Its Components And Non-muscle Invasive Bladder Cancer
193. Postoperative Adjuvant Iliac Artery Perfusion Chemotherapy For The Treatment Of High-risk Non-muscular Invasion Efficacy Of Bladder Cancer:A Meta-analysis
194. Laparoscopic Radical Cystectomy Combined With Neoadjuvant Chemotherapy In Muscle-Infiltrating Invasive Bladder Cancer
195. Construction Of A Model To Predict The Risk Of Recurrence Of Non-muscle Invasive Bladder Cancer Using Pathological Images Combined With Deep Learning
196. Clinical Prognostic Correlation Of Molecular Subtypes In Muscular Invasive Bladder Cancer
197. The Expression And Function Of YT521-B Homeodomain-Containing Protein 1 In Muscle-Invasive Bladder Cancer
198. Comparison Of Efficacy And Safety Of Total Cystectomy And Bladder Preservation In The Treatment Of Muscular Invasive Bladder Cancer
199. Prognostic Nutritional Index Combined With NLR To Construct A Survival Prediction Model And Decision Analysis Of Patients With Muscle-invasive Bladder Cancer After Surgery
200. Predictive Role Of RPN1 In The Recurren Of Non-muscle Invasive Bladder Cancer After Surgery
  <<First  <Prev  Next>  Last>>  Jump to